Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Aug;1812(8):893-908.
doi: 10.1016/j.bbadis.2010.10.006. Epub 2010 Oct 20.

Role of nuclear receptor SHP in metabolism and cancer

Affiliations
Review

Role of nuclear receptor SHP in metabolism and cancer

Yuxia Zhang et al. Biochim Biophys Acta. 2011 Aug.

Abstract

Small heterodimer partner (SHP, NR0B2) is a unique member of the nuclear receptor (NR) superfamily that contains the dimerization and ligand-binding domain found in other family members, but lacks the conserved DNA-binding domain. The ability of SHP to bind directly to multiple NRs is crucial for its physiological function as a transcriptional inhibitor of gene expression. A wide variety of interacting partners for SHP have been identified, indicating the potential for SHP to regulate an array of genes in different biological pathways. In this review, we summarize studies concerning the structure and target genes of SHP and discuss recent progress in understanding the function of SHP in bile acid, cholesterol, triglyceride, glucose, and drug metabolism. In addition, we review the regulatory role of SHP in microRNA (miRNA) regulation, liver fibrosis and cancer progression. The fact that SHP controls a complex set of genes in multiple metabolic pathways suggests the intriguing possibility of developing new therapeutics for metabolic diseases, including fatty liver, dyslipidemia and obesity, by regulating SHP with small molecules. To achieve this goal, more progress regarding SHP ligands and protein structure will be required. Besides its metabolic regulatory function, studies by us and other groups provide strong evidence that SHP plays a critical role in the development of cancer, particularly liver and breast cancer. An increased understanding of the fundamental mechanisms by which SHP regulates the development of cancers will be critical in applying knowledge of SHP in diagnostic, therapeutic or preventive strategies for specific cancers. This article is part of a Special Issue entitled: Translating nuclear receptors from health to disease.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest exist for the authors.

Figures

Figure 1
Figure 1. Domain structure of the orphan nuclear receptor SHP
Classical nuclear receptor (NR) contains five major functional domains: the N-terminal ligand-independent transactivation domain (A/B domain), the DNA binding domain (DBD or C domain), hinge region (D domain), the C-terminal ligand-binding domain (LBD or E domain), and the ligand-dependent transactivation domain (AF2 or F domain). Compared to the classical NRs, SHP contains the dimerization and LBD domain, but lacks the conserved DBD. SHP represses the transcriptional activities of its targets gene by utilizing two functional LXXLL-related motifs (also called NR-boxes) which are located in the putative N-terminal helix 1 of the LBD and in the C-terminal region of helix 5.
Figure 2
Figure 2. Schematic overview of nuclear receptors (NRs) and transcription receptors (TFs) regulating the promoter of the human SHP gene
Location of the binding sites of NRs and TFs and the consensus sequences are indicated in the human SHP gene promoter. NRs that target SHP promoter include hepatocyte nuclear factor 4a (HNF4α), steroidogenic factor-1 (SF-1), liver receptor homolog-1 (LRH-1), farnesoid X receptor (FXR), estrogen receptor a (ERα), liver X receptor α (LXRα), upstream stimulatory factor-1 (USF-1), estrogen receptor related receptor γ (ERRγ), and peroxisome proliferator-activated receptor γ (PPARγ). TFs that induce SHP expression include E47, c-Jun, sterol regulatory element binding protein -1c (SREBP-1c) and circadian locomotor output cycles kaput (CLOCK)/brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1(Bmal1).
Figure 3
Figure 3. Model of three distinct transcriptional repression mechanisms for SHP
SHP represses nuclear receptor (NR) or transcription factor (TF) mediated transactivation by competition for coactivator binding to NR (I), recruitment of SHP-associated corepressors (II), and inhibition of DNA binding (III). SHP can utilize these three inhibitory steps alternatively or sequentially in a cell type and target gene specific manner.
Figure 4
Figure 4. Integrated view of SHP as a central transcriptional coregulator in diverse physiological pathways in the liver
Activation pathways are shown as broken blue arrows and inhibitory pathways are shown as broken red lines. FA, fatty acid; TG, triglyceride; VLDL, very low density lipoprotein; CYP7A1, cytochrome P450 enzyme cholesterol 7α-hydroxylase; G6P, glucose-6-phosphatase; HNF-4α, hepatocyte nuclear factor 4 α; JNK, c-jun N-terminal kinase; LRH-1, liver receptor homolog-1; LXR, liver X receptor; MTP, microsomal triglyceride transfer protein; PEPCK, phosphoenolpyruvate carboxykinase; PPARγ, peroxisome proliferator activated receptor γ; SHP, small heterodimer partner; SREBP-1c, sterol regulatory element binding protein-1c; WAT, white adipose tissue; and BAT, brown adipose tissue.

References

    1. Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov. 2004;3:950–964. - PubMed
    1. Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science. 1996;272:1336–1339. - PubMed
    1. Lee HK, Lee YK, Park SH, Kim YS, Lee JW, Kwon HB, Soh J, Moore DD, Choi HS. Structure and expression of the orphan nuclear receptor SHP gene. J Biol Chem. 1998;273:14398–14402. - PubMed
    1. Johansson L, Bavner A, Thomsen JS, Farnegardh M, Gustafsson JA, Treuter E. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors. Mol Cell Biol. 2000;20:1124–1133. - PMC - PubMed
    1. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. 2006;126:789–799. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources